AllianceBernstein’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-349,739
| Closed | -$8.26M | – | 3196 |
|
|
2023
Q4 | $8.26M | Buy |
349,739
+248,739
| +246% | +$4.43M | ﹤0.01% | 1259 |
|
|
2023
Q3 | $1.51M | Hold |
101,000
| – | – | ﹤0.01% | 2031 |
|
|
2023
Q2 | $1.11M | Buy |
+101,000
| New | +$940K | ﹤0.01% | 2228 |
|
|
2022
Q2 | – | Sell |
-106,600
| Closed | -$332K | – | 3420 |
|
|
2022
Q1 | $332K | Buy |
106,600
+400
| +0.4% | +$1.26K | ﹤0.01% | 2840 |
|
|
2021
Q4 | $359K | Hold |
106,200
| – | – | ﹤0.01% | 2885 |
|
|
2021
Q3 | $388K | Hold |
106,200
| – | – | ﹤0.01% | 2858 |
|
|
2021
Q2 | $463K | Buy |
106,200
+8,600
| +9% | +$38.1K | ﹤0.01% | 2840 |
|
|
2021
Q1 | $443K | Hold |
97,600
| – | – | ﹤0.01% | 2712 |
|
|
2020
Q4 | $560K | Sell |
97,600
-9,000
| -8% | -$68.1K | ﹤0.01% | 2544 |
|
|
2020
Q3 | $772K | Hold |
106,600
| – | – | ﹤0.01% | 2302 |
|
|
2020
Q2 | $372K | Sell |
106,600
-30,800
| -22% | -$88.9K | ﹤0.01% | 2791 |
|
|
2020
Q1 | $203K | Buy |
137,400
+20,600
| +18% | +$34.6K | ﹤0.01% | 2796 |
|
|
2019
Q4 | $229K | Hold |
116,800
| – | – | ﹤0.01% | 2879 |
|
|
2019
Q3 | $598K | Buy |
116,800
+6,800
| +6% | +$41.2K | ﹤0.01% | 2475 |
|
|
2019
Q2 | $788K | Buy |
110,000
+49,600
| +82% | +$562K | ﹤0.01% | 2413 |
|
|
2019
Q1 | $802K | Sell |
60,400
-7,300
| -11% | -$77.6K | ﹤0.01% | 2341 |
|
|
2018
Q4 | $533K | Hold |
67,700
| – | – | ﹤0.01% | 2452 |
|
|
2018
Q3 | $750K | Hold |
67,700
| – | – | ﹤0.01% | 2455 |
|
|
2018
Q2 | $909K | Buy |
+67,700
| New | +$847K | ﹤0.01% | 2360 |
|
|
2017
Q1 | – | Sell |
-204,256
| Closed | -$353K | – | 3042 |
|
|
2016
Q4 | $353K | Sell |
204,256
-6,475
| -3% | -$11.4K | ﹤0.01% | 2678 |
|
|
2016
Q3 | $409K | Sell |
210,731
-24,243
| -10% | -$48.2K | ﹤0.01% | 2600 |
|
|
2016
Q2 | $409K | Hold |
234,974
| – | – | ﹤0.01% | 2583 |
|
|
2016
Q1 | $317K | Hold |
234,974
| – | – | ﹤0.01% | 2564 |
|
|
2015
Q4 | $397K | Hold |
234,974
| – | – | ﹤0.01% | 2528 |
|
|
2015
Q3 | $456K | Hold |
234,974
| – | – | ﹤0.01% | 2517 |
|
|
2015
Q2 | $632K | Hold |
234,974
| – | – | ﹤0.01% | 2506 |
|
|
2015
Q1 | $1.63M | Hold |
234,974
| – | – | ﹤0.01% | 1879 |
|
|
2014
Q4 | $2.31M | Hold |
234,974
| – | – | ﹤0.01% | 1645 |
|
|
2014
Q3 | $1.61M | Buy |
+234,974
| New | +$1.44M | ﹤0.01% | 1878 |
|
Other funds holding CBAY
AllianceBernstein's CBAY Position: Q1 2024 in Review
AllianceBernstein sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 349,739 shares — an estimated $8.26M sold.
AllianceBernstein first reported a position in CBAY in Q3 2014 and held it in 29 quarters. The position peaked at $8.26M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.
- AllianceBernstein reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
- AllianceBernstein sold 349,739 Cymabay Therapeutics shares in Q1 2024, an estimated $8.26M.
- AllianceBernstein first reported a position in Cymabay Therapeutics in Q3 2014 and held it in 29 quarters.
- AllianceBernstein's Cymabay Therapeutics position peaked at $8.26M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.
Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.